v3.26.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

The following is a summary of the disaggregation of revenue for the three and six months ended June 30, 2026 and 2025: 

 

   2026   2025   2026   2025 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Product revenue - distribution services  $66,765   $7,548,600   $292,430   $18,216,887 
Pharmacy retail sales   1,590,367    77,756    2,724,783    192,432 
Third party logistics services   122,728    164,509    322,210    244,989 
Net revenues  $1,779,860   $7,790,865   $3,339,423   $18,654,308 
SCHEDULE OF POTENTIALLY DILUTIVE ITEMS OUTSTANDING

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the six months ended June 30, 2026 and 2025:

 

   2026   2025 
   June 30, 
   2026   2025 
         
Unvested restricted common stock   10,714    201,401 
Unissued director share awards   9,200    - 
Warrants   9,442,355    - 
Convertible notes   20,323,732    - 
Total potentially dilutive shares   29,786,001    201,401